Short-Term Outcomes of Refractory Diabetic Macular Edema Switch From Ranibizumab to Dexamethasone Implant and the Influential Factors: A Retrospective Real World Experience

Short-Term Outcomes of Refractory Diabetic Macular Edema Switch From Ranibizumab to Dexamethasone Implant and the Influential Factors: A Retrospective Real World Experience

Introduction: To evaluate the effectiveness and safety of intravitreal dexamethasone (DEX) implants in refractory diabetic macular edema (DME) treated by intravitreal ranibizumab.Materials and Methods: We retrospectively analyzed DME patients who received DEX implant treatment after being refractory...

Full description

Bibliographic Details
Main Authors: Ning-Yi Hsia, Chun-Ju Lin, Huan-Sheng Chen, Cheng-Hsien Chang, Henry Bair, Chun-Ting Lai, Jane-Ming Lin, Wen-Lu Chen, Peng-Tai Tien, Wen-Chuan Wu, Yi-Yu Tsai
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-04-01
Series:Frontiers in Medicine
Subjects:
diabetic macular edema
intravitreal dexamethasone implant
intravitreal ranibizumab
ozurdex
refractory diabetic macular edema
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2021.649979/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2021.649979/full

Similar Items